Cadila Pharma Launches Esomeprazole Tablets For Treatment Of Hyperacidity

Ahmedabad-based Cadila Pharmaceuticals Limited announced the launch of esomeprazole tablets for the treatment of hyperacidity and drug induced gastritis under the brand name Esiloc.In an endeavor to improve the treatment options available for hyperacidity & drug induced gastritis, Esiloc will be 50% more economical, thus making it a superior yet affordable choice. Esiloc will be made available in 20 mg and 40 mg tablets.Esomeprazole which is a proton pump inhibitor (PPI), acts on the luminal surface of gastric parietal cells, resulting in inhibition of acid secretion. Esomeprazole provides higher rates of healing of erosive GERD and sustained resolution of heartburn in patients.Gastro-oesophageal reflux (GERD) is reflux of gastric contents into the esophagus. Heartburn is a very common symptom of GERD. GERD is often overseen and if untreated, can lead to conditions like peptic ulcer, chest pain, esophagus cancer & other fatal conditions.Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies of India. It has recently concluded and cleared US FDA inspection successfully in February 2020. Over the past six decades, Cadila Pharmaceuticals has been engaged in the development and manufacturing of affordable medicines and in making them available for patients across the world. Its innovation-driven drug discovery processes ensure the health and well-being of people around the world

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!